AARTI DRUGS
|
AARTI DRUGS Last 5 Year Income Statement History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹2,529 Cr | ₹2,716 Cr | ₹2,489 Cr | ₹2,155 Cr | ₹1,806 Cr |
Sales | ₹2,509 Cr | ₹2,706 Cr | ₹2,489 Cr | ₹2,155 Cr | ₹1,806 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹20 Cr | ₹10 Cr | - | - | - |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹2,529 Cr | ₹2,716 Cr | ₹2,489 Cr | ₹2,155 Cr | ₹1,806 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹26 Cr | ₹-1.76 Cr | ₹-86 Cr | ₹-12 Cr | ₹-51 Cr |
Raw Material Consumed | ₹1,580 Cr | ₹1,815 Cr | ₹1,701 Cr | ₹1,275 Cr | ₹1,179 Cr |
Opening Raw Materials | ₹197 Cr | ₹222 Cr | ₹199 Cr | ₹122 Cr | ₹94 Cr |
Purchases Raw Materials | ₹1,486 Cr | ₹1,669 Cr | ₹1,614 Cr | ₹1,241 Cr | ₹1,118 Cr |
Closing Raw Materials | ₹183 Cr | ₹197 Cr | ₹222 Cr | ₹199 Cr | ₹122 Cr |
Other Direct Purchases / Brought in cost | ₹80 Cr | ₹121 Cr | ₹109 Cr | ₹111 Cr | ₹88 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹154 Cr | ₹156 Cr | ₹128 Cr | ₹98 Cr | ₹104 Cr |
Electricity & Power | ₹151 Cr | ₹153 Cr | ₹126 Cr | ₹96 Cr | ₹102 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | ₹3.46 Cr | ₹3.12 Cr | ₹2.62 Cr | ₹2.65 Cr | ₹2.11 Cr |
Employee Cost | ₹91 Cr | ₹80 Cr | ₹69 Cr | ₹66 Cr | ₹61 Cr |
Salaries, Wages & Bonus | ₹87 Cr | ₹77 Cr | ₹66 Cr | ₹62 Cr | ₹57 Cr |
Contributions to EPF & Pension Funds | ₹2.42 Cr | ₹2.31 Cr | ₹2.38 Cr | ₹2.17 Cr | ₹2.25 Cr |
Workmen and Staff Welfare Expenses | ₹1.39 Cr | ₹1.50 Cr | ₹1.36 Cr | ₹1.33 Cr | ₹1.77 Cr |
Other Employees Cost | - | - | - | - | - |
Other Manufacturing Expenses | ₹253 Cr | ₹242 Cr | ₹231 Cr | ₹181 Cr | ₹160 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹84 Cr | ₹76 Cr | ₹79 Cr | ₹67 Cr | ₹60 Cr |
Repairs and Maintenance | ₹19 Cr | ₹21 Cr | ₹13 Cr | ₹10 Cr | ₹8.24 Cr |
Packing Material Consumed | ₹46 Cr | ₹48 Cr | ₹49 Cr | ₹36 Cr | ₹32 Cr |
Other Mfg Exp | ₹104 Cr | ₹96 Cr | ₹89 Cr | ₹68 Cr | ₹60 Cr |
General and Administration Expenses | ₹29 Cr | ₹29 Cr | ₹30 Cr | ₹29 Cr | ₹21 Cr |
Rent , Rates & Taxes | - | - | - | - | - |
Insurance | ₹7.68 Cr | ₹7.68 Cr | ₹7.88 Cr | ₹7.04 Cr | ₹6.83 Cr |
Printing and stationery | ₹0.21 Cr | ₹0.20 Cr | ₹0.16 Cr | ₹0.09 Cr | ₹0.29 Cr |
Professional and legal fees | ₹5.59 Cr | ₹5.66 Cr | ₹6.34 Cr | ₹5.55 Cr | ₹3.82 Cr |
Traveling and conveyance | ₹2.55 Cr | ₹2.02 Cr | ₹1.36 Cr | ₹0.71 Cr | ₹1.22 Cr |
Other Administration | ₹13 Cr | ₹13 Cr | ₹15 Cr | ₹16 Cr | ₹9.23 Cr |
Selling and Distribution Expenses | ₹64 Cr | ₹76 Cr | ₹74 Cr | ₹71 Cr | ₹59 Cr |
Advertisement & Sales Promotion | ₹2.33 Cr | ₹1.17 Cr | ₹1.35 Cr | ₹0.98 Cr | ₹1.55 Cr |
Sales Commissions & Incentives | ₹13 Cr | ₹19 Cr | ₹15 Cr | ₹23 Cr | ₹25 Cr |
Freight and Forwarding | ₹40 Cr | ₹46 Cr | ₹51 Cr | ₹40 Cr | ₹27 Cr |
Handling and Clearing Charges | ₹5.99 Cr | ₹5.58 Cr | ₹5.49 Cr | ₹5.93 Cr | ₹4.80 Cr |
Other Selling Expenses | ₹1.95 Cr | ₹3.80 Cr | ₹2.02 Cr | ₹1.41 Cr | ₹0.91 Cr |
Miscellaneous Expenses | ₹11 Cr | ₹11 Cr | ₹8.95 Cr | ₹5.54 Cr | ₹6.88 Cr |
Bad debts /advances written off | ₹1.90 Cr | ₹1.53 Cr | ₹1.69 Cr | ₹0.85 Cr | ₹3.85 Cr |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | ₹0.18 Cr | - | - | - | - |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹9.40 Cr | ₹9.08 Cr | ₹7.26 Cr | ₹4.70 Cr | ₹3.03 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹2,208 Cr | ₹2,407 Cr | ₹2,156 Cr | ₹1,714 Cr | ₹1,541 Cr |
Operating Profit (Excl OI) | ₹321 Cr | ₹309 Cr | ₹333 Cr | ₹440 Cr | ₹266 Cr |
Other Income | ₹4.03 Cr | ₹2.19 Cr | ₹11 Cr | ₹4.53 Cr | ₹1.48 Cr |
Interest Received | ₹2.50 Cr | ₹0.70 Cr | ₹0.72 Cr | ₹2.60 Cr | ₹1.13 Cr |
Dividend Received | ₹0.00 Cr | ₹0.00 Cr | ₹1.60 Cr | ₹1.02 Cr | ₹0.00 Cr |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | - | - | - | - | - |
Others | ₹1.53 Cr | ₹1.49 Cr | ₹9.00 Cr | ₹0.91 Cr | ₹0.35 Cr |
Operating Profit | ₹325 Cr | ₹312 Cr | ₹344 Cr | ₹445 Cr | ₹267 Cr |
Interest | ₹38 Cr | ₹37 Cr | ₹24 Cr | ₹26 Cr | ₹37 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹6.14 Cr | ₹9.93 Cr | ₹12 Cr | ₹17 Cr | ₹19 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹4.37 Cr | ₹3.85 Cr | ₹3.16 Cr | ₹3.27 Cr | ₹3.70 Cr |
Other Interest | ₹27 Cr | ₹23 Cr | ₹9.05 Cr | ₹6.44 Cr | ₹15 Cr |
PBDT | ₹287 Cr | ₹275 Cr | ₹320 Cr | ₹419 Cr | ₹230 Cr |
Depreciation | ₹51 Cr | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹49 Cr |
Profit Before Taxation & Exceptional Items | ₹236 Cr | ₹224 Cr | ₹270 Cr | ₹369 Cr | ₹181 Cr |
Exceptional Income / Expenses | - | - | - | ₹0.23 Cr | ₹4.47 Cr |
Profit Before Tax | ₹236 Cr | ₹224 Cr | ₹270 Cr | ₹369 Cr | ₹185 Cr |
Provision for Tax | ₹64 Cr | ₹58 Cr | ₹65 Cr | ₹89 Cr | ₹44 Cr |
Current Income Tax | ₹60 Cr | ₹59 Cr | ₹70 Cr | ₹93 Cr | ₹46 Cr |
Deferred Tax | ₹4.37 Cr | ₹-1.04 Cr | ₹-4.78 Cr | ₹-4.46 Cr | ₹-9.45 Cr |
Other taxes | - | - | - | ₹0.08 Cr | ₹7.30 Cr |
Profit After Tax | ₹172 Cr | ₹166 Cr | ₹205 Cr | ₹280 Cr | ₹141 Cr |
Extra items | - | - | - | - | - |
Minority Interest | ₹-0.17 Cr | ₹-0.05 Cr | ₹0.04 Cr | ₹0.02 Cr | ₹0.00 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹171 Cr | ₹166 Cr | ₹205 Cr | ₹280 Cr | ₹141 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹1,021 Cr | ₹879 Cr | ₹754 Cr | ₹592 Cr | ₹496 Cr |
Appropriations | ₹1,192 Cr | ₹1,045 Cr | ₹959 Cr | ₹872 Cr | ₹637 Cr |
General Reserves | ₹14 Cr | ₹15 Cr | ₹20 Cr | ₹26 Cr | ₹14 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹13 Cr | ₹-0.02 Cr | ₹51 Cr | ₹69 Cr | ₹27 Cr |
Equity Dividend % | ₹10.00 | ₹10.00 | ₹10.00 | ₹25.00 | ₹20.00 |
Earnings Per Share | ₹18.65 | ₹17.96 | ₹22.14 | ₹30.09 | ₹60.69 |
Adjusted EPS | ₹18.65 | ₹17.96 | ₹22.14 | ₹30.09 | ₹15.17 |
Compare Income Statement of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹4,712.9 Cr | 1.3% | 5.3% | -2.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,626.0 Cr | 2% | 1.4% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,996.0 Cr | 1.3% | 0.3% | 10.4% | Stock Analytics | |
CIPLA | ₹127,494.0 Cr | 0.3% | 1.9% | -6.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,718.0 Cr | 0% | -2.3% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,374.0 Cr | 0.5% | 6.2% | -1.4% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | 1.3% |
5.3% |
-2.8% |
SENSEX | 1.8% |
2.1% |
0.2% |
You may also like the below Video Courses